Share-based Payment Arrangement, Expense in USD of IVERIC bio, Inc. from 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IVERIC bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2011 to Q1 2023.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2023 was $11.9M, a 121% increase year-over-year.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2023 was $33.2M, a 131% increase year-over-year.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.7M, a 137% increase from 2021.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.2M, a 35.1% increase from 2020.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $8.32M, a 9.34% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IVERIC bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $33.2M $11.9M +$6.51M +121% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $26.7M $8.35M +$4.1M +96.5% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023
Q3 2022 $22.6M $6.56M +$3.93M +150% 01 Jul 2022 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 $18.6M $6.39M +$4.31M +207% 01 Apr 2022 30 Jun 2022 10-Q 26 Jul 2022
Q1 2022 $14.3M $5.39M +$3.09M +135% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $11.2M $4.25M +$1.97M +86.4% 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $9.28M $2.63M +$779K +42.2% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022
Q2 2021 $8.5M $2.08M +$206K +11% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022
Q1 2021 $8.29M $2.29M -$32K -1.38% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $8.32M $2.28M -$98K -4.12% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 $8.42M $1.85M -$279K -13.1% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $8.7M $1.87M -$334K -15.1% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $9.03M $2.32M -$146K -5.91% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $9.18M $2.38M -$347K -12.7% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022
Q3 2019 $9.53M $2.13M -$478K -18.4% 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020
Q2 2019 $10M $2.21M -$455K -17.1% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $10.5M $2.47M -$612K -19.9% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $11.1M $2.72M -$984K -26.5% 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2021
Q3 2018 $12.1M $2.6M -$807K -23.7% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $12.9M $2.66M -$2.33M -46.6% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 $15.2M $3.08M -$2.98M -49.2% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $18.2M $3.71M -$3.06M -45.2% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020
Q3 2017 $21.2M $3.41M -$4.84M -58.6% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 $26.1M $4.99M -$3.32M -40% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $29.4M $6.06M -$2.27M -27.2% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $31.7M $6.77M +$485K +7.72% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019
Q3 2016 $31.2M $8.25M +$1.21M +17.1% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017
Q2 2016 $30M $8.31M +$1.93M +30.3% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017
Q1 2016 $28M $8.33M +$3.28M +64.9% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $24.8M $6.29M +$2.74M +77.2% 01 Oct 2015 31 Dec 2015 10-K 05 Mar 2018
Q3 2015 $22M $7.04M +$3.46M +96.7% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 $18.6M $6.38M +$3.2M +100% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 $15.4M $5.05M +$2.33M +85.2% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 $13M $3.55M +$2.28M +181% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017
Q3 2014 $10.8M $3.58M +$2.43M +212% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $8.32M $3.18M +$2.83M +804% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $5.49M $2.73M +$2.62M +2427% 01 Jan 2014 31 Mar 2014 10-Q/A 28 Jul 2015
Q4 2013 $2.87M $1.26M 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016
Q3 2013 $1.15M +$997K +665% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 $352K 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 $108K 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014
Q3 2012 $150K 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013

IVERIC bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $26.7M +$15.4M +137% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023
2021 $11.2M +$2.92M +35.1% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023
2020 $8.32M -$857K -9.34% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 $9.18M -$1.89M -17.1% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 $11.1M -$7.1M -39.1% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021
2017 $18.2M -$13.5M -42.6% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $31.7M +$6.9M +27.9% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 $24.8M +$11.7M +89.9% 01 Jan 2015 31 Dec 2015 10-K 05 Mar 2018
2014 $13M +$10.2M +354% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 $2.87M +$2.23M +349% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016
2012 $640K +$392K +158% 01 Jan 2012 31 Dec 2012 10-K/A 28 Jul 2015
2011 $248K 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.